Financials
- Market Capitalization 2.06 B
- Employee 128
- Founded 2012
- CEO N/A
- Website www.auriniapharma.com
- Headquarter Alberta, Canada
- FIGI BBG000BCRJM5
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
6.83
ratio cours/chiffre d'affaires
6.83
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1968 | ABCL AbCellera Biologics Inc. - Common Shares | 6.74 USD | +3.37% | -8.80% | +28.87% | +69.77% | 2.06 B USD | ||
| 1969 | ADMA ADMA Biologics Inc - Common Stock | 8.87 USD | -1.11% | -1.55% | +4.97% | -50.72% | 2.06 B USD | ||
| 1971 | NUVB Nuvation Bio Inc. Class A Common Stock | 5.90 USD | +2.43% | +6.50% | +15.23% | +174.42% | 2.05 B USD | ||
| 1980 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 18.20 USD | +4.54% | +1.85% | +19.74% | +123.59% | 2.02 B USD |